Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

China flag China · Delayed Price · Currency is CNY
13.95
+0.02 (0.14%)
Apr 29, 2026, 3:00 PM CST
10.28%
Market Cap 7.90B
Revenue (ttm) 3.29B
Net Income (ttm) 303.93M
Shares Out 566.16M
EPS (ttm) 0.54
PE Ratio 25.83
Forward PE 22.50
Dividend n/a
Ex-Dividend Date n/a
Volume 4,435,200
Average Volume 5,555,047
Open 13.91
Previous Close 13.93
Day's Range 13.87 - 14.06
52-Week Range 12.55 - 20.20
Beta 0.60
RSI 48.82
Earnings Date Apr 23, 2026

About SHA:600557

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China. [Read more]

Sector Healthcare
Founded 1975
Employees 6,132
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600557
Full Company Profile

Financial Performance

In 2025, SHA:600557's revenue was 3.29 billion, a decrease of -15.52% compared to the previous year's 3.90 billion. Earnings were 303.93 million, a decrease of -22.44%.

Financial Statements

News

There is no news available yet.